Publication | Open Access
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
105
Citations
28
References
2018
Year
Liver and lung metastases and a poor performance status are independent predictors of nivolumab efficacy in patients with advanced non-small cell lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1